The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis

The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis

BackgroundThe Lung Immune Prognostic Index (LIPI) combines the lactate dehydrogenase (LDH) level and the derived neutrophil-to-lymphocyte ratio (dNLR). A lot of studies have shown that LDH and dNLR are associated with the prognosis of advanced non-small cell lung cancer (NSCLC) in patients treated w...

Full description

Bibliographic Details
Main Authors: Qianning Zhang, Xiaoling Gong, Lei Sun, Liyun Miao, Yujie Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
lactate dehydrogenase
derived neutrophil-to-lymphocyte ratio
immunotherapy
non-small cell lung cancer
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.791496/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.791496/full

Similar Items